⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8402944 | 1.00 | — | — | |
| SCHEMBL41343 | 1.00 | — | — | |
| SCHEMBL14740517 | 1.00 | — | — | |
| SCHEMBL6237929 | 1.00 | — | — | |
| SCHEMBL119256 | 1.00 | — | — | |
| SCHEMBL27790660 | 1.00 | — | — | |
| SCHEMBL753185 | 1.00 | — | — | |
| SCHEMBL2451945 | 1.00 | — | — | |
| SCHEMBL11692372 | 1.00 | — | — | |
| SCHEMBL166257 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105188771-A | Myo-inositol trispyrophosphate as an anti-obesity agent | NORMOXYS INC | 2015-12-23 | — | — | CN | disclosed |
| CN-103495170-A | Method of reducing multi-drug resistance using inositol tripyrophosphate | UNIV STRASBOURG | 2014-01-08 | — | — | CN | disclosed |
| CN-102573853-A | Methods for reducing multidrug resistance using inositol tripyrophosphate | NORMOXYS INC | 2012-07-11 | — | — | CN | disclosed |
| CN-101784193-A | Erythropoietin complementation or substitution | OXYPLUS INC | 2010-07-21 | — | — | CN | disclosed |